Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations

Chih-Yen Tu, Chuan-Mu Chen, Wei-Chih Liao, Biing-Ru Wu, Chih-Yu Chen, Wei-Chun Chen, Te-Chun Hsia, Wen-Chien Cheng, Chia-Hung Chen
  • Oncotarget, February 2018, Impact Journals, LLC
  • DOI: 10.18632/oncotarget.24386

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.18632/oncotarget.24386